Bullboard Post History

by health1234

Order by:

T.VRX	Sequoia Fund add on Sequoia Fund Managers Ruane Cunniff Take Valeant Stake Above 10% bloomberg... November 13, 2015
T.VRX	RE:RE:ValueAct buying shares from yesterday $74.STILL BUYING Form 4 from ValueAct on Microsoft Shows Disclosure of Share Sale by valueact... November 13, 2015
T.VRX	ValueAct buying shares from yesterday $74.STILL BUYING GOOD NEWS ARE COMING FROM NEXT WEEK,FOR SURE November 13, 2015
T.CXR.R	i love this part of report Approximately 60 per cent of revenues to be generated outside the United... November 12, 2015
T.CXR.R	A transformational quarter strong performance by legacy bu A transformational quarter with strong performance by legacy business. good... November 12, 2015
T.CXR.R	NASDAQ Biotechnology Index - 72 Not a single biotac share was green in both markets. NASDAQ... November 12, 2015
T.CXR.R	volume at 2.30 am can 178000k stabilty November 11, 2015
T.VRX	volume at 2.20 can 400k US 1.1 M only stability November 11, 2015
T.CXR.R	RE:earnings on Thursday evening 1-fears of budget proposal impact hit health care stocks in US. 2... November 10, 2015
T.VRX	Valeant Turns to Drug Discounts to Keep Doctors Prescribing l After drawing criticism for... November 10, 2015
T.CXR.R	Will 'Virtual Biotechs' Make Drugs Cheaper? Ingrid Swanson Pultz's biotech company lacks most of the standard... November 10, 2015
T.VRX	JPMorgan Analyst Defends Valeant, Cites Continued Performanc Call Highlights Below are a few highlights from JPMorgan’s report. 1... November 10, 2015
T.VRX	short interest nasdaq- now 1M before 2 days 35M. Short Interest: NYSE Company By Company \| Nasdaq \| NYSE MKTSHORT INTEREST... November 10, 2015
T.VRX	moody's ---------------- Moody's affirms Valeant's Ba3 ratings - The rating... November 10, 2015
T.VRX	credibility. regulations? How can people give Citron Research so much credibility and ignore analyst... November 10, 2015
T.CXR.R	credibility. How can people give Citron Research so much credibility and ignore analyst... November 10, 2015
T.VRX	' Valeant's structure may not be illegal "Fairly ... soon Valeant will have identified a new specialty pharmacy... November 9, 2015
T.CXR.R	RE:RE:RE:RE:Break the $40 mark today? Stock price makes a new room WHEN volume is under 250k. WITHOUT NEWS... November 9, 2015
T.CXR.R	These markets are in 'pure bull' mode: Strategist-CNBC Monday board and health sector are showing green sign inculding VRX. November 8, 2015
T.CXR.R	RE:drug price reduction -solution?! thank for the link November 8, 2015

Become a member today, It's free!

Bullboard Post History

by health1234

Sequoia Fund add on

RE:RE:ValueAct buying shares from yesterday $74.STILL BUYING

ValueAct buying shares from yesterday $74.STILL BUYING

i love this part of report

A transformational quarter strong performance by legacy bu

NASDAQ Biotechnology Index - 72

volume at 2.30 am can 178000k

volume at 2.20 can 400k US 1.1 M only

RE:earnings on Thursday evening

Valeant Turns to Drug Discounts to Keep Doctors Prescribing

Will 'Virtual Biotechs' Make Drugs Cheaper?

JPMorgan Analyst Defends Valeant, Cites Continued Performanc

short interest nasdaq- now 1M before 2 days 35M.

moody's

credibility. regulations?

credibility.

' Valeant's structure may not be illegal

RE:RE:RE:RE:Break the $40 mark today?

These markets are in 'pure bull' mode: Strategist-CNBC

RE:drug price reduction -solution?!

Featured News Links

Do you want to stay ahead of the markets? See how DealRoom can help.

Featured Company

Kootenay Silver Inc. V.KTN

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by health1234

Featured News Links

Featured Company